{"id":23669,"date":"2010-02-26T12:51:17","date_gmt":"2010-02-26T18:51:17","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=23669"},"modified":"2018-04-14T02:05:05","modified_gmt":"2018-04-14T07:05:05","slug":"23669","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/pt\/23669\/","title":{"rendered":"Not\u00edcias e notas de sa\u00fade animal de 26 de fevereiro de 2010"},"content":{"rendered":"<p><a target=\"_blank\" href=\"\/wp-content\/uploads\/2018\/01\/AHN_2-26-10.pdf\">vers\u00e3o para impress\u00e3o<\/a><\/p>\n<p>************************************<br \/>\n<strong>Brakke Consulting&#039;s <br \/>\nNot\u00edcias e notas de sa\u00fade animal de 26 de fevereiro de 2010<\/strong><br \/>\nCopyright \u00a9 Brakke Consulting, Inc.<br \/>\n&nbsp;<br \/>\nEditor: Lynn Fondon, DVM, MBA <br \/>\n************************************<br \/>\nNAS NOTICIAS:<br \/>\n&nbsp;<br \/>\n<u>not\u00edcias de Brakke<\/u><br \/>\nservi\u00e7os de recrutamento<br \/>\n&nbsp;<br \/>\n<u>not\u00edcias de ganhos<br \/>\n<\/u>alfarma<br \/>\nGrupo de Cuidados com Animais<br \/>\nBayer<br \/>\nDechra<br \/>\nHeska<br \/>\n&nbsp;<br \/>\n<u>outras not\u00edcias<\/u><br \/>\nAesculap<br \/>\nBioCurex<br \/>\nIgreja e Dwight<br \/>\nCVS<br \/>\nLloyd<br \/>\nDiagn\u00f3stico OncoPet<br \/>\nPBI\/Gordon<br \/>\nScil<br \/>\nEmpresas veterin\u00e1rias e com\u00e9rcio <br \/>\n&nbsp;<br \/>\n************************************<br \/>\n<strong>BRAKKE CONSULTING, INC.<br \/>\nSERVI\u00c7OS DE RECRUTAMENTO<\/strong><br \/>\n&nbsp;<br \/>\nDesde 1986, a Brakke Consulting tem auxiliado com sucesso muitos clientes na aquisi\u00e7\u00e3o de funcion\u00e1rios excepcionais em todos os n\u00edveis, nos v\u00e1rios departamentos de sa\u00fade animal, animais de estima\u00e7\u00e3o e empresas veterin\u00e1rias. Pr\u00e9-qualificamos os candidatos, permitindo que os clientes escolham apenas os melhores candidatos para uma vaga. A nossa abordagem aumenta a efici\u00eancia e efic\u00e1cia dos Departamentos de Recursos Humanos das empresas clientes. Para obter mais informa\u00e7\u00f5es, visite nosso site e clique no link \u201cRecrutamento\u201d em Nossos servi\u00e7os.<br \/>\n&nbsp;<br \/>\n<a href=\"http:\/\/www.BrakkeConsulting.com\">www.BrakkeConsulting.com<\/a><br \/>\n&nbsp;<br \/>\n************************************<br \/>\nRELEASES DE RESULTADOS DA EMPRESA<br \/>\n&nbsp;<br \/>\n&gt; A Bayer reportou resultados para o ano inteiro de 2009. As receitas de sa\u00fade animal foram de EUR 977 milh\u00f5es ($1.400 milh\u00f5es), um aumento de 1% em compara\u00e7\u00e3o com o ano anterior. (site da companhia) <br \/>\n&nbsp;<br \/>\n&gt; A King Pharmaceuticals, Inc. anunciou os resultados do ano encerrado em 31 de dezembro de 2009. A receita l\u00edquida do neg\u00f3cio Alpharma Animal Health totalizou $359 milh\u00f5es, inalterada em rela\u00e7\u00e3o ao ano anterior. (site da companhia) <br \/>\n&nbsp;<br \/>\n&gt; A Dechra Pharmaceuticals divulgou resultados para o semestre encerrado em 31 de dezembro. A receita total foi de GBP 185 milh\u00f5es ($294 milh\u00f5es), um aumento de 7% em compara\u00e7\u00e3o com o per\u00edodo compar\u00e1vel do ano anterior. A receita l\u00edquida de produtos farmac\u00eauticos foi de GBP 40,6 milh\u00f5es ($65 milh\u00f5es), um aumento de 14% em rela\u00e7\u00e3o ao per\u00edodo compar\u00e1vel do ano anterior. (comunicado de imprensa da empresa) <br \/>\n&nbsp;<br \/>\n&gt; A Heska informou os resultados financeiros de 2009. A receita do ano foi de $75,7 milh\u00f5es, uma queda de 7% em compara\u00e7\u00e3o com o ano anterior. O lucro l\u00edquido foi de $2,2 milh\u00f5es em compara\u00e7\u00e3o com um preju\u00edzo l\u00edquido de ($850.000) em 2008. (comunicado de imprensa da empresa) <br \/>\n&nbsp;<br \/>\n&gt; O Animalcare Group plc, sediado no Reino Unido, reportou resultados para os seis meses encerrados em 31 de dezembro de 2009. A receita no primeiro semestre aumentou para GBP 8,9 milh\u00f5es ($14,2 milh\u00f5es) de GBP 7,8 milh\u00f5es no per\u00edodo do ano anterior, impulsionada principalmente pelas receitas da divis\u00e3o de animais de companhia. O lucro de seis meses cresceu para GBP 547.000 ($871.000) de GBP 65.000 no per\u00edodo do ano anterior. (RTTNews) <br \/>\n&nbsp;<br \/>\n************************************<br \/>\nCOMUNICADOS DE NOT\u00cdCIAS DA EMPRESA<br \/>\n&nbsp;<br \/>\n&gt; A Lloyd, Inc. anunciou o lan\u00e7amento da solu\u00e7\u00e3o est\u00e9ril Butorphic (tartarato de butorfanol). Butorphic (10 mg\/mL) ser\u00e1 embalado em convenientes frascos multiuso de 20 mL. (site da companhia) <br \/>\n&nbsp;<br \/>\n&gt; A BioCurex anunciou o lan\u00e7amento do OncoPet RECAF, um novo teste para detec\u00e7\u00e3o de c\u00e2ncer em c\u00e3es. O produto funciona detectando a presen\u00e7a de Recaf, um marcador de crescimento de c\u00e9lulas malignas em humanos e animais. A empresa estabeleceu uma subsidi\u00e1ria, a OncoPet Diagnostics, para oferecer o novo servi\u00e7o de testes a veterin\u00e1rios e laborat\u00f3rios cl\u00ednicos de animais. Ela comercializar\u00e1 e comercializar\u00e1 o servi\u00e7o globalmente, tanto diretamente quanto por meio de parcerias locais e internacionais. (Farm\u00e1cia Animal) <br \/>\n&nbsp;<br \/>\n&gt; A scil animal care company, inc., anunciou uma parceria de elite com a Aesculap, uma divis\u00e3o do Grupo B. Braun. A Scil \u00e9 agora a distribuidora exclusiva da linha de produtos cir\u00fargicos Power Systems da Aesculap para o mercado veterin\u00e1rio norte-americano. (comunicado de imprensa da empresa)&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; A PBI\/Gordon Corp. anunciou a aquisi\u00e7\u00e3o da linha Lambert Kay de produtos para animais de estima\u00e7\u00e3o da Church &amp; Dwight Co. A aquisi\u00e7\u00e3o fortalece a presen\u00e7a da PBI\/Gordon no mercado de produtos para animais de estima\u00e7\u00e3o, aumentando as linhas de produtos Trophy e Prozyme da empresa. Os termos financeiros n\u00e3o foram divulgados. (comunicado de imprensa da empresa) <br \/>\n&nbsp;<br \/>\n&gt; A CVS, consolidadora veterin\u00e1ria do Reino Unido, anunciou a aquisi\u00e7\u00e3o da Veterinary Enterprises &amp; Trading. A Veterinary Enterprises opera sob a marca Pet Doctors e possui 27 consult\u00f3rios veterin\u00e1rios no sudeste da Inglaterra. A empresa tamb\u00e9m possui o neg\u00f3cio de diagn\u00f3stico e laborat\u00f3rio veterin\u00e1rio Greendale. CVS agora opera mais de 170 cirurgias veterin\u00e1rias em todo o pa\u00eds. (mandadeals.co.uk)<br \/>\n&nbsp;<br \/>\n***********************************<br \/>\nNOT\u00cdCIAS DE SA\u00daDE ANIMAL<br \/>\n&nbsp;<br \/>\n&gt; EUA \u2013 VACINA\u00c7\u00c3O CONTRA BRUCELOSE O veterin\u00e1rio estadual de Montana est\u00e1 pressionando pela vacina\u00e7\u00e3o contra brucelose para todas as bezerras sexualmente intactas, argumentando que a mudan\u00e7a \u00e9 necess\u00e1ria para controlar doen\u00e7as e manter o gado Big Sky comercializ\u00e1vel, e colocaria Montana em linha com as medidas j\u00e1 tomadas em Wyoming e Idaho. Membros de dois dos maiores grupos pecu\u00e1rios de Montana, a Montana Stockgrowers Association e a Montana Farm Bureau Federation, formalizaram pol\u00edticas que se op\u00f5em oficialmente \u00e0 vacina\u00e7\u00e3o de todas as bezerras sexualmente intactas porque acham que \u00e9 desnecess\u00e1rio. (AVMA SmartBrief)<br \/>\n&nbsp;<br \/>\n&gt; EUA \u2013 SA\u00daDE P\u00daBLICA VETERIN\u00c1RIA O Centro de Medicina Veterin\u00e1ria P\u00fablica e Corporativa, parte do Col\u00e9gio Regional de Medicina Veterin\u00e1ria da Virg\u00ednia-Maryland, fez parceria com a Associa\u00e7\u00e3o de Sa\u00fade Animal dos EUA. (USAHA) para criar oportunidades de orienta\u00e7\u00e3o, educa\u00e7\u00e3o e networking para veterin\u00e1rios e estudantes de veterin\u00e1ria. Em resposta ao aumento da demanda por veterin\u00e1rios no setor p\u00fablico, o centro est\u00e1 trabalhando para expandir suas atividades nas \u00e1reas de sa\u00fade p\u00fablica, pol\u00edticas p\u00fablicas, medicina veterin\u00e1ria internacional, lideran\u00e7a organizacional e One Health Initiative. (alimentos)<br \/>\n&nbsp;<br \/>\n************************************<br \/>\nPONTO DE VISTA DA BRAKKE CONSULTORIA<br \/>\n&nbsp;<br \/>\nOs resultados financeiros da empresa no final do ano de 2009 continuaram a ser uma mistura de algumas empresas mostrando aumentos e outras diminuindo. Conforme observado em boletins anteriores, 2009 foi um ano desafiador e, se n\u00e3o fosse pelos aumentos de pre\u00e7os, o crescimento da receita para o ano teria ficado abaixo da queda j\u00e1 projetada de 2% para o ano. <br \/>\n&nbsp;<br \/>\nContinuamos preocupados com a redu\u00e7\u00e3o do n\u00famero de novos produtos que foram lan\u00e7ados em 2009 e que se repetem em 2010. Sem novidades significativas para auxiliar no crescimento das vendas, 2010 parece caminhar para uma repeti\u00e7\u00e3o do ano passado.&nbsp; <br \/>\n&nbsp;<br \/>\nAcreditamos que o n\u00famero decrescente de novos produtos pode ser atribu\u00eddo aos or\u00e7amentos totais de pesquisa e desenvolvimento reduzidos, juntamente com a crescente dificuldade de obter a aprova\u00e7\u00e3o do FDA e do USDA para produtos no sistema regulat\u00f3rio. A boa not\u00edcia \u00e9 que h\u00e1 uma s\u00e9rie de novas tecnologias buscando financiamento ou acordos de licenciamento em andamento. Esperan\u00e7osamente, as ag\u00eancias reguladoras ter\u00e3o o conhecimento interno e a estrutura para avaliar e mover adequadamente essas novas tecnologias atrav\u00e9s do labirinto de obst\u00e1culos regulat\u00f3rios.&nbsp;&nbsp; <br \/>\n&nbsp;<br \/>\nTenha um bom fim de semana!!<br \/>\n&nbsp;<br \/>\nRon Brakke<br \/>\n&nbsp;<br \/>\n************************************<br \/>\nEste boletim eletr\u00f4nico \u00e9 propriedade exclusiva da Brakke Consulting, Inc.<br \/>\nQualquer uso do conte\u00fado deste documento deve ser aprovado e devidamente atribu\u00eddo \u00e0 Brakke Consulting, Inc.<\/p>\n<p>Para obter mais informa\u00e7\u00f5es sobre os servi\u00e7os e estudos sindicados da Brakke Consulting, visite nosso website em <a href=\"https:\/\/brakkeconsulting.com\/pt\/\">www.brakkeconsulting.com<\/a>.<br \/>\n&nbsp;<br \/>\nBrakke Consulting, Inc.<br \/>\n2735 Villa Creek, Su\u00edte 140<br \/>\nDallas, TX 75234 EUA<\/p>","protected":false},"excerpt":{"rendered":"<p>vers\u00e3o para impress\u00e3o ************************************ Not\u00edcias e notas sobre sa\u00fade animal da Brakke Consulting para 26 de fevereiro de 2010 Copyright \u00a9 Brakke Consulting, Inc. Editor: Lynn Fondon, DVM, MBA ********************************** ** NAS NOT\u00cdCIAS: Not\u00edcias de Brakke Not\u00edcias sobre ganhos de servi\u00e7os de recrutamento Alpharma Animalcare Group Bayer Dechra Heska outras not\u00edcias Aesculap BioCurex Church &amp; Dwight CVS Lloyd OncoPet Diagnostics PBI \/ Gordon scil Veterinary Enterprises &amp; Trading ************* *********************** BRAKKE CONSULTING, INC. SERVI\u00c7OS DE RECRUTAMENTO Desde 1986, a Brakke Consulting tem auxiliado com sucesso muitos clientes na aquisi\u00e7\u00e3o de funcion\u00e1rios excepcionais em todos os n\u00edveis, nos muitos departamentos de sa\u00fade animal, animais de estima\u00e7\u00e3o e empresas veterin\u00e1rias. Pr\u00e9-qualificamos os candidatos, permitindo que os clientes escolham apenas os melhores candidatos para uma vaga. Nossa abordagem aumenta a efici\u00eancia e efic\u00e1cia dos Departamentos de Recursos Humanos das empresas clientes. Para obter mais informa\u00e7\u00f5es, visite nosso site e clique no link \u201cRecrutamento\u201d em Nossos Servi\u00e7os. www.BrakkeConsulting.com ************************************ DIVULGA\u00c7\u00d5ES DE RESULTADOS DA EMPRESA &gt; A Bayer divulgou resultados para o ano completo de 2009. As receitas de sa\u00fade animal foram de 977 milh\u00f5es de euros ($1.400 milh\u00f5es), um aumento de 1% em compara\u00e7\u00e3o com o ano anterior. (site da empresa) &gt; King Pharmaceuticals, Inc. anunciou resultados para o ano encerrado em 31 de dezembro de 2009. A receita l\u00edquida do neg\u00f3cio Alpharma Animal Health totalizou $359 milh\u00f5es, inalterada em rela\u00e7\u00e3o ao ano anterior. (site da empresa) &gt; Dechra Pharmaceuticals relatou resultados do semestre<\/p>\n<div class=\"view-full-post\"><a href=\"https:\/\/brakkeconsulting.com\/pt\/23669\/\" class=\"view-full-post-btn\">Ver postagem completa<\/a><\/div>\n<p>;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-23669","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/pt\/23669\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"printer friendly version ************************************ Brakke Consulting&rsquo;s Animal Health News &amp; Notes for February 26, 2010 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon, DVM, MBA ************************************ IN THE NEWS: &nbsp; Brakke news Recruiting services &nbsp; earnings news Alpharma Animalcare Group Bayer Dechra Heska &nbsp; other news Aesculap BioCurex Church &amp; Dwight CVS Lloyd OncoPet Diagnostics PBI\/Gordon scil Veterinary Enterprises &amp; Trading &nbsp; ************************************ BRAKKE CONSULTING, INC. RECRUITING SERVICES &nbsp; Since 1986 Brakke Consulting has successfully assisted many clients in acquiring exceptional employees at all levels, in the many departments of animal health, pet, and veterinary companies.&nbsp;&nbsp; We pre-qualify candidates, allowing clients to choose from only the best applicants for a position.&nbsp; Our approach increases the efficiency and effectiveness of the Human Resources Departments of client companies. For more information, visit our website and click on the &#8220;Recruiting&#8221; link under Our Services. &nbsp; www.BrakkeConsulting.com &nbsp; ************************************ COMPANY EARNINGS RELEASES &nbsp; &gt; Bayer reported results for the full year 2009.&nbsp; Animal health revenues were EUR 977 million ($1,400 million), an increase of 1% compared to the prior year. (company website) &nbsp; &gt; King Pharmaceuticals, Inc. announced results for the year ended December 31, 2009. Net revenue from the Alpharma Animal Health business totaled $359 million, unchanged from the prior year. (company website) &nbsp; &gt; Dechra Pharmaceuticals reported results for the half-yearView Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/pt\/23669\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2010-02-26T18:51:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-04-14T07:05:05+00:00\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/23669\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/23669\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Animal Health News &#038; Notes for February 26, 2010\",\"datePublished\":\"2010-02-26T18:51:17+00:00\",\"dateModified\":\"2018-04-14T07:05:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/23669\/\"},\"wordCount\":1056,\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/23669\/\",\"url\":\"https:\/\/brakkeconsulting.com\/ja\/23669\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#website\"},\"datePublished\":\"2010-02-26T18:51:17+00:00\",\"dateModified\":\"2018-04-14T07:05:05+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/23669\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/ja\/23669\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/23669\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News &#038; Notes for February 26, 2010\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Not\u00edcias da Brakke Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/pt\/23669\/","og_locale":"pt_PT","og_type":"article","og_title":"News from Brakke Consulting","og_description":"printer friendly version ************************************ Brakke Consulting&rsquo;s Animal Health News &amp; Notes for February 26, 2010 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon, DVM, MBA ************************************ IN THE NEWS: &nbsp; Brakke news Recruiting services &nbsp; earnings news Alpharma Animalcare Group Bayer Dechra Heska &nbsp; other news Aesculap BioCurex Church &amp; Dwight CVS Lloyd OncoPet Diagnostics PBI\/Gordon scil Veterinary Enterprises &amp; Trading &nbsp; ************************************ BRAKKE CONSULTING, INC. RECRUITING SERVICES &nbsp; Since 1986 Brakke Consulting has successfully assisted many clients in acquiring exceptional employees at all levels, in the many departments of animal health, pet, and veterinary companies.&nbsp;&nbsp; We pre-qualify candidates, allowing clients to choose from only the best applicants for a position.&nbsp; Our approach increases the efficiency and effectiveness of the Human Resources Departments of client companies. For more information, visit our website and click on the &#8220;Recruiting&#8221; link under Our Services. &nbsp; www.BrakkeConsulting.com &nbsp; ************************************ COMPANY EARNINGS RELEASES &nbsp; &gt; Bayer reported results for the full year 2009.&nbsp; Animal health revenues were EUR 977 million ($1,400 million), an increase of 1% compared to the prior year. (company website) &nbsp; &gt; King Pharmaceuticals, Inc. announced results for the year ended December 31, 2009. Net revenue from the Alpharma Animal Health business totaled $359 million, unchanged from the prior year. (company website) &nbsp; &gt; Dechra Pharmaceuticals reported results for the half-yearView Full Post;","og_url":"https:\/\/brakkeconsulting.com\/pt\/23669\/","og_site_name":"Brakke Consulting Website","article_published_time":"2010-02-26T18:51:17+00:00","article_modified_time":"2018-04-14T07:05:05+00:00","author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Brakke Consulting","Tempo estimado de leitura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/ja\/23669\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/ja\/23669\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Animal Health News &#038; Notes for February 26, 2010","datePublished":"2010-02-26T18:51:17+00:00","dateModified":"2018-04-14T07:05:05+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/ja\/23669\/"},"wordCount":1056,"articleSection":["Newsletter"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/ja\/23669\/","url":"https:\/\/brakkeconsulting.com\/ja\/23669\/","name":"Not\u00edcias da Brakke Consulting","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/#website"},"datePublished":"2010-02-26T18:51:17+00:00","dateModified":"2018-04-14T07:05:05+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/ja\/23669\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/ja\/23669\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/ja\/23669\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Animal Health News &#038; Notes for February 26, 2010"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/#website","url":"https:\/\/brakkeconsulting.com\/","name":"Site da Brakke Consulting","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"Brakke Consultoria","url":"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23669","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/comments?post=23669"}],"version-history":[{"count":1,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23669\/revisions"}],"predecessor-version":[{"id":25144,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23669\/revisions\/25144"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/media?parent=23669"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/categories?post=23669"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/tags?post=23669"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}